ArticleJournal of global oncology2018
Advancing Reliable Data for Cancer Control in the Central America Four Region.
Abstract read
In one paragraph
Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Colorectal Cancer Screening Programs in Latin America: A Systematic Review and Meta-Analysis.JAMA network open · 2024Pooled it
- Randomized, Double-Blind, Placebo-Controlled Trial of Meriva (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis.Cancer prevention research (Philadelphia, Pa.) · 2026Trial
- Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-Blinded, Randomized Clinical Trial.Cancer prevention research (Philadelphia, Pa.) · 2026Trial
- Was It Worth It? Response Data from >650 US and International Participants in Chemoprevention Trials.Cancer prevention research (Philadelphia, Pa.) · 2026Article
- High Seroprevalence ofGastroenterology research · 2025Article
- Gastric cancer in Central America: a scoping review.Ecancermedicalscience · 2025Review
- Population-Based Study of Gastric Cancer Survival and Associations in Rural Western Honduras.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Article
- High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024Article
- Enduring association between irritable bowel syndrome and war trauma during the Nicaragua civil war period: A population-based study.World journal of gastroenterology · 2023Article
- History of the National Cancer Registry of Panama.Journal of registry management · 2023Article
- Sex and age differences in mortality trends of gastric cancer among Hispanic/Latino populations in the United States, Latin America, and the Caribbean.Lancet regional health. Americas · 2022Article
- Western Honduras Copán Population-Based Cancer Registry: Initial Estimates and a Model for Rural Central America.JCO global oncology · 2021Article
- Prevalence and Associated Dietary Factors of Rome IV Functional Gastrointestinal Disorders in Rural Western Honduras.Digestive diseases and sciences · 2021Article
- Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap.Journal of the National Cancer Institute · 2021Article
- Aflatoxin and the Etiology of Liver Cancer and Its Implications for Guatemala.World mycotoxin journal · 2021Article
- Helicobacter pylori antimicrobial resistance and antibiotic consumption in the low-resource Central America setting.Helicobacter · 2019Article
- Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.BMC cancer · 2019Article
- Liver Cancer in Guatemala: An Analysis of Mortality and Incidence Trends From 2012 to 2016.Journal of global oncology · 2019Article
- Political priority and pathways to scale-up of childhood cancer care in five nations.PloS one · 2019Article
- Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.Journal of global oncology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Marion PiñerosMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Silvina FrechMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Lindsay FrazierMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Mathieu LaversanneMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Joaquin BarnoyaMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Claudia GarridoMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Eduardo GharzouziMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Andrea ChacónMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Soad Fuentes AlabiMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Lisseth Ruiz de CamposMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Jacqueline FigueroaMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Ricardo DominguezMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Ofelia RojasMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Rosario PereiraMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Carla RiveraMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Douglas R MorganMarion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children's Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.
Funding
Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8MProject 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8MCCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS P01 CA028842NCI NIH HHS P30 CA068485World Health Organization 001
Abstract
The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices, and unified with open borders in 2006. The growing CA-4 cancer burden among the noncommunicable diseases is expected to increase 73% by 2030, which argues for a regional approach to cancer control. This has driven efforts to establish population-based cancer registries as a central component of the cancer control plans. The involvement of international and academic partners in an array of initiatives to improve cancer information and control in the CA-4 has accelerated over the past several years. Existing data underscore that the infectious cancers (cervical, stomach, and liver) are a particular burden. All four countries have committed to establishing regional population-based cancer registries and have advanced significantly in pediatric cancer registration. The challenges common to each nation include the lack of national cancer control plans and departments, competing health priorities, lack of trained personnel, and sustainability strategies. General recommendations to address these challenges are outlined. The ongoing regional, international, and academic cooperation has proven helpful and is expected to continue to be a powerful instrument to contribute to the design and implementation of long-term national cancer control plans.
Indexed as
Data AccuracyCentral AmericaCost of IllnessDemographyHumansIncidenceMortalityNeoplasmsPartnership PracticePublic Health SurveillanceRegistries
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.